Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping Neuro Behcet's Disease Across North Africa: a Systematic Review and Meta Analysis.

Clinical reviews in allergy & immunology·2026
Same author

Acute Myeloid Leukemia Presenting As Spontaneous Splenic Rupture: A Case Report.

Cureus·2026
Same author

Thrombopoietin receptor agonists in immune thrombocytopenia: a comparative review of mechanisms, efficacy, and the future of personalized management.

Expert opinion on pharmacotherapy·2026
Same author

Correction: Zulfiqar et al. Association of Frailty Status with Risk of Fall among Hospitalized Elderly Patients: A Cross-Sectional Study in an Acute Geriatric Unit. <i>Medicines</i> 2022, <i>9</i>, 48.

Medicines (Basel, Switzerland)·2026
Same author

Factors Influencing the Use of G-CSF in Drug-Induced Agranulocytosis.

Hematology reports·2026
Same author

The Effectiveness of Infliximab in Treating Vascular Manifestations of Behçet's Disease: A Systematic Review and Meta-Analysis.

Mediterranean journal of rheumatology·2026

Related Experiment Videos

[Nutritional anemias in elderly patients].

Khalid Serraj1, Laure Federici, Georges Kaltenbach

  • 1Service de médecine interne, diabète et maladies métaboliques, Clinique médicale B, Hôpital civil, Hôpitaux universitaires de Strasbourg, F-67091 Strasbourg Cedex, France.

Presse Medicale (Paris, France : 1983)
|July 18, 2008
PubMed
Summary

Anemia in the elderly is often caused by nutritional deficiencies like iron, vitamin B12, and folate. Effective management requires addressing the underlying cause and supplementing nutrients, not just focusing on hemoglobin levels.

Related Experiment Videos

Area of Science:

  • Geriatric Medicine
  • Hematology
  • Nutritional Science

Context:

  • Anemia affects a significant portion of the elderly population.
  • Nutritional deficiencies account for one-third of anemia cases in older adults.
  • Anemia management urgency in the elderly is dictated by clinical tolerance and repercussions, not solely hemoglobin levels.

Purpose:

  • To highlight the prevalence and causes of anemia in the elderly.
  • To emphasize the importance of identifying specific nutritional deficiencies (iron, vitamin B12, folate).
  • To outline appropriate management strategies for anemia in geriatric patients.

Summary:

  • Nutritional deficiencies are a primary driver of anemia in the elderly.
  • Common deficiencies include iron, vitamin B12, and folate, necessitating diagnostic testing.
  • Chronic gastrointestinal bleeding is a leading cause of iron-deficiency anemia.
  • Treatment involves nutrient supplementation alongside etiological management.

Impact:

  • Improved diagnostic approaches for elderly anemia.
  • Enhanced therapeutic strategies focusing on root causes.
  • Better clinical outcomes and quality of life for anemic elderly patients.